Searched for
ORAL SOLID FORMULATIONS
BDR Pharma to acquire Acme’s oral solid formulations business- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%
- Every bad cycle ends the same way; problems find their own solutions: 5 large-cap stocks with upside potential of up to 27%
- Long-term investing is about looking beyond narratives, including AI: 5 large-caps with an upside potential of up to 24%As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...15 Oct, 2026, 04.19 PM IST
- 5 stocks with consistent score improvement and upside potential of up to 34% in 1 year, according to analystsGiven the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...12 Oct, 2026, 03.24 PM IST
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...07 Oct, 2026, 05.28 PM IST
- Akums Group inks pact worth 200 million euros for European marketAkums Group signed a long-term deal worth 200 million euros with a global pharma company. They will produce and supply oral liquid formulat...26 Dec, 2024, 04.43 PM IST
- WEF recognises DRL's Bachupally plant, Cipla's Indore OSD unit as part of Global Lighthouse NetworkA press release from the city-based drug maker said Lighthouses are factories leading the way in Fourth Industrial Revolution (Industry 4.0...11 Oct, 2022, 08.17 PM IST
- Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 croreSuven will purchase100% of share capital from CPPL existing investors. Suven didn't provide details like annual turnover of the acquired as...05 Apr, 2022, 08.48 PM IST
- Lupin receives EIR from USFDA for its Goa manufacturing site, shares gainLupin said USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI), which means USFDA w...14 Dec, 2021, 12.37 PM IST
- PAG to acquire contact manufacturer Acme FormulationFounded in 2005 by Viral Shah, Acme provides contract development and manufacturing services to major Indian and global pharmaceutical comp...22 Jul, 2021, 02.31 PM IST
- Alembic Pharma gets board approval to raise up to Rs 1,000 crore via QIPThe board, at its meeting held on Monday, has accorded its approval to raise up to Rs 1,000 crore through a QIP issue of equity shares.27 Jul, 2020, 01.25 PM IST
- Alembic Pharma gets VAI classification from USFDA for its Panelav facilityAs per the USFDA, VAI classification means that though objectionable conditions or practices were found, the agency is not prepared to take...04 May, 2020, 05.01 PM IST
- Alembic Pharma receives 4 observations from USFDA for Panelav facility"The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals general oral solid formulation facility...16 Mar, 2020, 11.31 AM IST
- USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory actionAccording to USFDA's definitions, OAI means "objectionable conditions were found and regulatory administrative sanctions by FDA are indicat...30 Jan, 2020, 12.48 PM IST
- Alembic Pharma jumps 3% as JV firm completes USFDA inspectionAlembic Pharma manufactures and markets generic pharmaceutical products across the globe.09 Jan, 2020, 03.47 PM IST
- Alembic Pharma plans Rs 720-crore capex for FY19The pharma firm has filed 12 ANDAs (abbreviated new drug applications) during the March quarter, taking the total filings in FY18 to 26.03 Jun, 2018, 04.45 PM IST
- Hold Aurobindo Pharma, target Rs 650: ICICI DirectHold Aurobindo Pharma Ltd. at a price target of Rs 650.0 .01 Jun, 2018, 10.01 AM IST
- USFDA finds company's SEZ Indore unit acceptable: Ipca LabsThis will enable the company to commercialise oral solid dosage formulations in the US market from this manufacturing facility.04 Sep, 2013, 02.07 PM IST
- Panacea's Baddi unit gets US FDA approvalDrug maker Panacea Biotec on Friday said its pharmaceutical facility at Baddi in Himachal Pradesh has received approval from US health regu...30 Apr, 2010, 01.38 PM IST
Load More
